About Penta
Who we are
Diversity and Inclusion
Our Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
A comparison of the pharmacokinetics of tenofovir during pregnancy and post-partum
A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe
Pharmacokinetics of 100/25 mg lopinavir/ritonavir tablets in children when dosed twice daily according to FDA weight bands.
Neurocognitive and Quality of Life Outcomes in Children after Planned Treatment Interruptions: the randomized PENTA 11 trial.
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011
Phylodynamic and Phylogeographic Patterns of the HIV-1 Subtype F1 Parenteral Epidemic in Romania.
Pharmacokinetics of 100/25 mg lopinavir/ritonavir tablets in children when dosed twice daily according to FDA weightbands.
Antiretroviral use in Italian children with perinatal HIV infection over a 14 – year period
Body Fat Abnormality in HIV-infected children and adoloscents living in Europe: prevalence and risk factors
Short and long term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.